Novartis AG
Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –
Novartis Total FTEs — ex-Sandoz, FY2023–FY2025 by Year
Novartis Total FTEs — ex-Sandoz, FY2023–FY2025: 75,267 in FY2025, down 0.8% from a year earlier.
Where the FY2025 figure comes from
“|| Total | 27 288 | 20 015 | 16 487 | 11 477 | 75 267”
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Keep only the FY2023–FY2025 series excluding Sandoz to ensure consistent comparison; expand the 2-dimensional Function × Region matrix below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total FTEs — ex-Sandoz, FY2023–FY2025 | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 75,267 | -0.8% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 75,883 | -0.2% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 76,057 | – | Novartis Form 20-F (0001114448-26-000004) ↗ |
Breakdown
What makes up total FTEs — ex-Sandoz, FY2023–FY2025
- Total Headcount — ex-Sandoz77,052 · FY2025
- Commercial Field Force FTEs17,491 · FY2025
- 1. Marketing & Sales FTEs27,288 · FY2025
- 2. Production & Supply FTEs16,487 · FY2025
- 3. Research & Development FTEs20,015 · FY2025
- 4. General & Administration FTEs11,477 · FY2025
- Overall Turnover (%)13.0% · FY2025
- Voluntary Turnover (%)7.0% · FY2025
- Female Representation in Total Global Workforce (%)52.0% · FY2025
- Overall Management Female (%)49.0% · FY2025
- Female Representation on the Board of Directors (%)42.0% · FY2025
- Executive Committee Female (%)20.0% · FY2025
- Global Mean Pay Gap (%)-1.7% · FY2025
- Percentage of Employees Represented by Unions / Collective Bargaining Agreements (%)57.0% · FY2025
- Number of Nationalities in the Global Workforce138 · FY2025
- Total Employee Benefits Expense13,200 · FY2025
- Share-Based Compensation Expense1,330 · FY2025
- Total Key Management Compensation109 · FY2025
Cite this data
StockData. (2026). Novartis Total FTEs — ex-Sandoz, FY2023–FY2025, annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/wf-fte-total
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.